Comparison of quality of life after bladder augmentation in patients previously treated with intradetrusor botulinum toxin A for neurogenic detrusor overactivity.
Bakali Issaui Z, Truong XQ, Genon M, Gaillet S, Tournebise H, Zini P, Bernuz B, Thiry Escudier I, Bardot P, Radot C, Muro C, Lenne Aurier K, Bonopera R, De Brier G, Boissier R, Lechevallier E, Karsenty G, Michel F.
Bakali Issaui Z, et al. Among authors: michel f.
Fr J Urol. 2024 Jul 24;34(10):102706. doi: 10.1016/j.fjurol.2024.102706. Online ahead of print.
Fr J Urol. 2024.
PMID: 39059768